SCF interacts with the receptor, c-kit, to enhance pro-inflammatory adaptive immunity (32, 88) that drives downstream effector mediators that include MCP chemokines, MCP-1 and MCP-3 (31), that were increased in lupus relatives, including those with clinical disease. Here, KIT is linked to systemic lupus erythematosus.